Treatment of Measles in Adults
Treatment of measles in adults is primarily supportive care with airborne isolation precautions (N-95 masks and airborne infection isolation rooms), while vitamin A supplementation should be considered particularly in hospitalized patients, immunocompromised individuals, or those with vitamin A deficiency 1, 2.
Isolation and Infection Control
Immediate implementation of airborne precautions is critical:
- Place patient in an airborne infection isolation room
- Healthcare workers must wear N-95 respirators
- Maintain isolation from rash onset until 4 days after rash appearance
- Measles is extraordinarily contagious through aerosolized respiratory secretions 1, 2
Supportive Care (Primary Treatment)
There is no FDA-approved antiviral therapy for measles 2, 3. Management focuses on:
- Hydration and fever management
- Monitoring for and treating secondary bacterial infections (otitis media, pneumonia, laryngotracheobronchitis) with appropriate antibiotics 2
- Nutritional support and rehydration for severe diarrhea 2
- Respiratory support as needed for pneumonitis or severe respiratory complications 4
Vitamin A Therapy
Vitamin A should be administered to adults who are hospitalized, immunocompromised, or have evidence of vitamin A deficiency 2, 5. While the World Health Organization primarily recommends this for children, the evidence supports its use in severe adult cases 4. The treatment data shows that at least two doses of vitamin A reduce measles mortality by 62% 6.
Key Considerations for Vitamin A:
- Most beneficial in hospitalized patients
- Particularly important in immunocompromised adults
- Should be physician-directed 7
- Oral formulation preferred when available 5
Special Populations Requiring Aggressive Management
Immunocompromised patients, pregnant women, and unvaccinated individuals require heightened vigilance 1:
- Immunocompromised: Higher risk for severe complications including measles inclusion body encephalitis; consider immune globulin if exposed within 6 days (0.5 mL/kg, maximum 15 mL) 8
- Pregnant women: Increased complication risk; immune globulin (0.25 mL/kg) if exposed, as vaccine is contraindicated 8
- Unvaccinated contacts: Post-exposure prophylaxis with MMR vaccine within 72 hours or immune globulin within 6 days 8
Monitoring for Complications
Vigilantly monitor for:
- Respiratory: Pneumonia, laryngotracheobronchitis (common complications) 2
- Neurological: Acute disseminated encephalomyelitis (rare but serious), subacute sclerosing panencephalitis (delayed) 2
- Other: Otitis media, stomatitis, severe diarrhea 2
Common Pitfalls
- Ribavirin is not effective in clinical practice despite theoretical appeal 4, 3
- Do not delay isolation while awaiting laboratory confirmation (serum IgM, viral RNA detection) 2
- Airborne precautions are mandatory—droplet precautions alone are insufficient 1
- Measles can present with milder symptoms in previously vaccinated individuals, maintaining high clinical suspicion 2